microdosing semaglutide vs tirzepatide GLP-1's for Weight Loss & Inflamation:-Dr Lipman, Miami Tirzepatide vs Semaglutide: Weight Loss,

This work alters our understanding of the events that drive the activation of class B receptors

Microdosing GLP-1 receptor agonists like semaglutide and tirzepatide represents a promising frontier for patients seeking metabolic benefits with improved tolerability

doi: 10.1111/obr.12755

Any menstrual changes are more likely related to weight loss and metabolic improvements rather than direct drug effects on the hypothalamic-pituitary-ovarian axis

A one-time dose of Beqvez reduced bleeds post-treatment compared to standard of care with a median of zero bleeds after up to three years of follow-up, Pfizer reported, adding that this could potentially help patients avoid years of treatment burden